Chief Executive Officer
Mon, Mar 16, 2026
Mar 16
2,770 shares @ $47.30
Decreased holdings by -0.90%
Net across this filing: 0.00% (+0 shares)
11th largest trade (out of 42)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
Price 135% above 200-day moving average
TERNTerns Pharmaceuticals, Inc.
HealthcareBiotechnology